| MDL | MFCD00078590 |
|---|---|
| Molecular Weight | 474.39 |
| Molecular Formula | C23H28BrN3O3 |
| SMILES | O=C1N(CCCCN2CCN(C3=CC=CC=C3OC)CC2)C(C4=C1C=CC=C4)=O.[H]Br |
|
5-HT 1 Receptor |
NAN-190 hydrobromide (0.5 mg/kg, ip) is injected concomitantly with the effective dose of fluoxetine. NAN-190 reverses the catalepsy-improving effect of fluoxetine in 6-OHDA lesioned rats [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
DMSO : 16.67 mg/mL ( 35.14 mM ; Need ultrasonic)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.1080 mL | 10.5399 mL | 21.0797 mL |
| 5 mM | 0.4216 mL | 2.1080 mL | 4.2159 mL |
| 10 mM | 0.2108 mL | 1.0540 mL | 2.1080 mL |
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 1.67 mg/mL (3.52 mM); Clear solution